A Single-center, Open-label, Fixed-sequence Trial to Investigate the Effect of Multiple-dose Aprocitentan on the Single-dose Pharmacokinetics of Combined Oral Contraceptives in Healthy Female Participants
Latest Information Update: 03 Feb 2025
Price :
$35 *
At a glance
- Drugs Aprocitentan (Primary) ; Contraceptives; Ethinylestradiol/levonorgestrel
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Idorsia Pharmaceuticals
- 03 Feb 2025 New trial record